IOL CHEMICALS & PHARM. | ZYDUS LIFESCIENCES | IOL CHEMICALS & PHARM./ ZYDUS LIFESCIENCES |
|||
---|---|---|---|---|---|
P/E (TTM) | x | 13.2 | 31.4 | 41.9% | View Chart |
P/BV | x | 1.5 | 5.3 | 28.3% | View Chart |
Dividend Yield | % | 1.0 | 0.7 | 159.9% |
IOL CHEMICALS & PHARM. ZYDUS LIFESCIENCES |
EQUITY SHARE DATA | |||||
---|---|---|---|---|---|
IOL CHEMICALS & PHARM. Mar-23 |
ZYDUS LIFESCIENCES Mar-23 |
IOL CHEMICALS & PHARM./ ZYDUS LIFESCIENCES |
5-Yr Chart Click to enlarge
|
||
High | Rs | 537 | 495 | 108.4% | |
Low | Rs | 272 | 319 | 85.2% | |
Sales per share (Unadj.) | Rs | 377.6 | 170.3 | 221.8% | |
Earnings per share (Unadj.) | Rs | 23.7 | 19.8 | 119.8% | |
Cash flow per share (Unadj.) | Rs | 31.6 | 26.9 | 117.3% | |
Dividends per share (Unadj.) | Rs | 4.00 | 6.00 | 66.7% | |
Avg Dividend yield | % | 1.0 | 1.5 | 67.1% | |
Book value per share (Unadj.) | Rs | 256.8 | 173.0 | 148.4% | |
Shares outstanding (eoy) | m | 58.71 | 1,012.20 | 5.8% | |
Bonus / Rights / Conversions | 0 | 0 | - | ||
Price / Sales ratio | x | 1.1 | 2.4 | 44.8% | |
Avg P/E ratio | x | 17.1 | 20.6 | 82.9% | |
P/CF ratio (eoy) | x | 12.8 | 15.1 | 84.7% | |
Price / Book Value ratio | x | 1.6 | 2.4 | 66.9% | |
Dividend payout | % | 16.9 | 30.3 | 55.6% | |
Avg Mkt Cap | Rs m | 23,743 | 412,144 | 5.8% | |
No. of employees | `000 | NA | NA | - | |
Total wages/salary | Rs m | 1,682 | 24,564 | 6.8% | |
Avg. sales/employee | Rs Th | 0 | 0 | - | |
Avg. wages/employee | Rs Th | 0 | 0 | - | |
Avg. net profit/employee | Rs Th | 0 | 0 | - |
INCOME DATA | |||||
---|---|---|---|---|---|
Net Sales | Rs m | 22,171 | 172,374 | 12.9% | |
Other income | Rs m | 256 | 4,746 | 5.4% | |
Total revenues | Rs m | 22,427 | 177,120 | 12.7% | |
Gross profit | Rs m | 2,257 | 29,677 | 7.6% | |
Depreciation | Rs m | 462 | 7,227 | 6.4% | |
Interest | Rs m | 165 | 1,299 | 12.7% | |
Profit before tax | Rs m | 1,887 | 25,897 | 7.3% | |
Minority Interest | Rs m | 0 | 0 | - | |
Prior Period Items | Rs m | 0 | 0 | - | |
Extraordinary Inc (Exp) | Rs m | 0 | 0 | - | |
Tax | Rs m | 495 | 5,878 | 8.4% | |
Profit after tax | Rs m | 1,391 | 20,019 | 7.0% | |
Gross profit margin | % | 10.2 | 17.2 | 59.1% | |
Effective tax rate | % | 26.2 | 22.7 | 115.6% | |
Net profit margin | % | 6.3 | 11.6 | 54.0% |
BALANCE SHEET DATA | |||||
---|---|---|---|---|---|
Current assets | Rs m | 9,667 | 100,082 | 9.7% | |
Current liabilities | Rs m | 5,025 | 55,267 | 9.1% | |
Net working cap to sales | % | 20.9 | 26.0 | 80.5% | |
Current ratio | x | 1.9 | 1.8 | 106.2% | |
Inventory Days | Days | 43 | 50 | 86.0% | |
Debtors Days | Days | 8 | 94 | 8.9% | |
Net fixed assets | Rs m | 11,017 | 144,776 | 7.6% | |
Share capital | Rs m | 587 | 1,012 | 58.0% | |
"Free" reserves | Rs m | 14,490 | 174,146 | 8.3% | |
Net worth | Rs m | 15,077 | 175,158 | 8.6% | |
Long term debt | Rs m | 0 | 0 | - | |
Total assets | Rs m | 20,684 | 244,940 | 8.4% | |
Interest coverage | x | 12.5 | 20.9 | 59.5% | |
Debt to equity ratio | x | 0 | 0 | - | |
Sales to assets ratio | x | 1.1 | 0.7 | 152.3% | |
Return on assets | % | 7.5 | 8.7 | 86.4% | |
Return on equity | % | 9.2 | 11.4 | 80.7% | |
Return on capital | % | 13.6 | 15.5 | 87.6% | |
Exports to sales | % | 26.7 | 39.2 | 68.2% | |
Imports to sales | % | 0 | 11.9 | 0.0% | |
Exports (fob) | Rs m | 5,930 | 67,577 | 8.8% | |
Imports (cif) | Rs m | NA | 20,544 | 0.0% | |
Fx inflow | Rs m | 5,930 | 67,577 | 8.8% | |
Fx outflow | Rs m | 6,052 | 20,544 | 29.5% | |
Net fx | Rs m | -122 | 47,033 | -0.3% |
CASH FLOW | |||||
---|---|---|---|---|---|
From Operations | Rs m | 1,223 | 26,888 | 4.5% | |
From Investments | Rs m | -1,200 | 11,712 | -10.2% | |
From Financial Activity | Rs m | -41 | -44,004 | 0.1% | |
Net Cashflow | Rs m | -18 | -5,338 | 0.3% |
Indian Promoters | % | 48.2 | 75.0 | 64.3% | |
Foreign collaborators | % | 0.0 | 0.0 | - | |
Indian inst/Mut Fund | % | 1.7 | 18.4 | 9.3% | |
FIIs | % | 1.4 | 5.7 | 24.5% | |
ADR/GDR | % | 0.0 | 0.0 | - | |
Free float | % | 51.8 | 25.0 | 207.1% | |
Shareholders | 130,003 | 294,324 | 44.2% | ||
Pledged promoter(s) holding | % | 0.0 | 0.0 | - |
Compare IOL CHEMICALS & PHARM. With: DIVIS LABORATORIES CIPLA SUN PHARMA DR. REDDYS LAB MANKIND PHARMA
No comparison is complete without understanding how the stock prices have performed over a period of time.
Here's a brief comparison:
Period | IOL CHEMICALS & PHARM. | Cadila Healthcare | S&P BSE HEALTHCARE |
---|---|---|---|
1-Day | -1.18% | -1.51% | -0.44% |
1-Month | -4.51% | -4.89% | 2.15% |
1-Year | -4.09% | 78.27% | 49.82% |
3-Year CAGR | -12.01% | 20.48% | 14.21% |
5-Year CAGR | 15.35% | 22.77% | 19.19% |
* Compound Annual Growth Rate
Here are more details on the IOL CHEMICALS & PHARM. share price and the Cadila Healthcare share price.
Moving on to shareholding structures...
The promoters of IOL CHEMICALS & PHARM. hold a 48.2% stake in the company. In case of Cadila Healthcare the stake stands at 75.0%.
To review how promoter stakes have changed over time, and how much of the promoter stake is pledged, please see the shareholding pattern of IOL CHEMICALS & PHARM. and the shareholding pattern of Cadila Healthcare.
Finally, a word on dividends...
In the most recent financial year, IOL CHEMICALS & PHARM. paid a dividend of Rs 4.0 per share. This amounted to a Dividend Payout ratio of 16.9%.
Cadila Healthcare paid Rs 6.0, and its dividend payout ratio stood at 30.3%.
You may visit here to review the dividend history of IOL CHEMICALS & PHARM., and the dividend history of Cadila Healthcare.
For a sector overview, read our pharmaceuticals sector report.
After opening the day deep in red, Indian share markets reversed the trend as the session progressed and ended on firm footing.